XML 53 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments (Level 3 Reconciliation) (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Assets:  
Fair value of level 3 financial instrument assets as of December 31, 2012 $ 13,960
Assumed payments made by Pfizer or assignee (2,450)
Fair value adjustments recorded as unrealized gain on available-for-sale securities 2,201
Fair value adjustments to co-promote termination liability 2,810
Fair value of level 3 financial instrument assets as of September 30, 2013 16,521
Liabilities  
Fair value of level 3 financial instrument liabilities as of December 31, 2012 23,647
Assumed payments made by Pfizer or assignee (2,450)
Fair value adjustments for amounts owed related to restricted investments and recorded as other expense 330
Payments to CVR and other former license holders (100)
Fair value adjustments to contingent liabilities (2,104)
Fair value adjustments to co-promote termination liability 2,810
Fair value of level 3 financial instrument liabilities as of September 30, 2013 $ 22,133